xDot Medical can begin FDA IDE study of vascular closure device
July 6, 2026
xDot Medical announced today that it received FDA investigational device exemption (IDE) approval for its access management system (AMS).
xDot Medical announced today that it received FDA investigational device exemption (IDE) approval for its access management system (AMS).
Movmedix announced today that it received FDA 510(k) clearance for its third-generation LARS ACJ synthetic ligament implant platform.
The CE marking by GMED recognises compliance with patient safety and clinical efficacy for Class IIb devices.
Visby’s multi-viral Medical Flu and Covid-19 test yields results in 30 minutes.
SINGAPORE, July 1, 2026 /PRNewswire/ — NICE Surgical Solutions Pte Ltd (“NICE Surgical”), a clinical-stage medical device company pioneering full intracorporeal anastomosis surgical instruments has been officially granted the U.S. Patent No. 12,653,527 B2, for its purse-string stapler.
SkylineDX’s test stratifies cutaneous melanoma patients into metastatic risk categories to inform treatment decisions.
BLOOMINGTON, Minn., June 30, 2026 /PRNewswire/ — Saluda Medical, Inc. (ASX: SLD, “Saluda” or the “Company”), a commercial-stage medical device company focused on developing treatments for chronic neurological conditions using its novel closed-loop neuromodulation platform, today announced that the U.S. Food and Drug Administration (“FDA”) has approved Saluda’s CAP24 paddle lead, allowing it to be marketed and sold in the U.S.
Sensitive test looking for key genetic mutation detects high-risk patients missed by standard testing
Aurenar announced today that it received FDA breakthrough device designation for its V-Link noninvasive neuromodulation system.
Novocure (Nasdaq:NVCR) announced today that its Optune Pax device for treating pancreatic cancer received CE mark approval.